name,category,termsGRP1 (general receptor for phosphoinositides 1)-associated scaffold protein,BIOCARTA[30000242$h_ptdinsPathway:Phosphoinositides and their downstream targets.]
GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF]
GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein,SMART[760000200$SM00228:PDZ]
GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001475$synapse]
GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein,UP_SEQ_FEATURE[850021009$chain:General receptor for phosphoinositides 1- associated scaffold protein, 850102586$compositionally biased region:Pro-rich, 850104918$domain:PDZ, 850105852$helix, 850106258$modified residue, 850112720$region of interest:Interaction with PSCD3, 850118574$splice variant, 850118575$strand, 850118624$turn]
K(lysine) acetyltransferase 2B,BBID[10000107$85.Nuc_Rec-Coact_Complex]
K(lysine) acetyltransferase 2B,BIOCARTA[30000221$h_pcafpathway:The information-processing pathway at the IFN-beta enhancer, 30000254$h_rarrxrPathway:Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells, 30000306$h_vdrPathway:Control of Gene Expression by Vitamin D Receptor]
K(lysine) acetyltransferase 2B,KEGG_PATHWAY[470038848$hsa04330:Notch signaling pathway]
K(lysine) acetyltransferase 2B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000025$Acyltransferase, 790000206$bromodomain, 790000258$cell cycle, 790000356$complete proteome, 790000733$host-virus interaction, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase]
K(lysine) acetyltransferase 2B,UP_SEQ_FEATURE[850023864$chain:Histone acetyltransferase KAT2B, 850103166$domain:Bromo, 850104817$domain:N-acetyltransferase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
TBC1 domain family, member 10B,INTERPRO[450000166$IPR000195:RabGAP/TBC]
TBC1 domain family, member 10B,SMART[760000143$SM00164:TBC]
TBC1 domain family, member 10B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000640$GTPase activation, 790001162$phosphoprotein]
TBC1 domain family, member 10B,UP_SEQ_FEATURE[850063652$chain:TBC1 domain family member 10B, 850102580$compositionally biased region:Poly-Pro, 850105135$domain:Rab-GAP TBC, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
U-box domain containing 5,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450003173$IPR003613:U box domain, 450016222$IPR017907:Zinc finger, RING-type, conserved site]
U-box domain containing 5,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
U-box domain containing 5,PIR_SUPERFAMILY[630028312$PIRSF036833:PIRSF036833]
U-box domain containing 5,SMART[760000158$SM00184:RING, 760000447$SM00504:Ubox]
U-box domain containing 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
U-box domain containing 5,UP_SEQ_FEATURE[850058218$chain:RING finger protein 37, 850105596$domain:U-box, 850117295$sequence variant, 850118911$zinc finger region:RING-type]
UPF1 regulator of nonsense transcripts homolog (yeast),COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
UPF1 regulator of nonsense transcripts homolog (yeast),INTERPRO[450006333$IPR006935:Restriction endonuclease, type I, R subunit/Type III, Res subunit, 450017269$IPR018999:RNA helicase UPF1, UPF2-interacting domain]
UPF1 regulator of nonsense transcripts homolog (yeast),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000649$helicase, 790000743$hydrolase, 790000937$metal-binding, 790001043$nonsense-mediated mrna decay, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
UPF1 regulator of nonsense transcripts homolog (yeast),UP_SEQ_FEATURE[850057061$chain:Regulator of nonsense transcripts 1, 850102392$compositionally biased region:Ala/Gly/Pro-rich, 850102504$compositionally biased region:Gln/Ser-rich, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850114790$region of interest:Sufficient for interaction with RENT2, 850117294$sequence conflict, 850117295$sequence variant, 850117812$short sequence motif:[ST]-Q motif 1, 850117813$short sequence motif:[ST]-Q motif 2, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118740$zinc finger region:C2H2-type; atypical, 850118762$zinc finger region:C4-type]
Wolf-Hirschhorn syndrome candidate 1,INTERPRO[450000267$IPR000313:PWWP, 450000793$IPR000910:High mobility group, HMG1/HMG2, 450001068$IPR001214:SET, 450001628$IPR001841:Zinc finger, RING-type, 450001740$IPR001965:Zinc finger, PHD-type, 450003176$IPR003616:Post-SET zinc-binding region, 450005980$IPR006560:AWS, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
Wolf-Hirschhorn syndrome candidate 1,KEGG_PATHWAY[470038751$hsa00310:Lysine degradation]
Wolf-Hirschhorn syndrome candidate 1,OMIM_DISEASE[520005107$Wolf-Hirschhorn syndrome]
Wolf-Hirschhorn syndrome candidate 1,SMART[760000158$SM00184:RING, 760000221$SM00249:PHD, 760000264$SM00293:PWWP, 760000286$SM00317:SET, 760000349$SM00398:HMG, 760000451$SM00508:PostSET, 760000507$SM00570:AWS]
Wolf-Hirschhorn syndrome candidate 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000311$chromatin regulator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000937$metal-binding, 790000954$methyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001271$Proto-oncogene, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
Wolf-Hirschhorn syndrome candidate 1,UP_SEQ_FEATURE[850042344$chain:Probable histone-lysine N- methyltransferase NSD2, 850102920$DNA-binding region:HMG box, 850103074$domain:AWS, 850105053$domain:Post-SET, 850105127$domain:PWWP 1, 850105128$domain:PWWP 2, 850105340$domain:SET, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2, 850118883$zinc finger region:PHD-type 3, 850118885$zinc finger region:PHD-type 4; atypical]
ariadne homolog 2 (Drosophila),INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450001661$IPR001878:Zinc finger, CCHC-type, 450002535$IPR002867:Zinc finger, C6HC-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site]
ariadne homolog 2 (Drosophila),PIR_SUPERFAMILY[630029695$PIRSF038109:Protein ariadne-2]
ariadne homolog 2 (Drosophila),SMART[760000158$SM00184:RING, 760000311$SM00343:ZnF_C2HC, 760000562$SM00647:IBR]
ariadne homolog 2 (Drosophila),SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
ariadne homolog 2 (Drosophila),UP_SEQ_FEATURE[850045104$chain:Protein ariadne-2 homolog, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118829$zinc finger region:IBR-type, 850118913$zinc finger region:RING-type 1; atypical, 850118915$zinc finger region:RING-type 2]
calcium channel, voltage-dependent, N type, alpha 1B subunit,INTERPRO[450001840$IPR002077:Voltage-dependent calcium channel, alpha-1 subunit, 450004906$IPR005447:Voltage-dependent calcium channel, N-type, alpha-1 subunit, 450005268$IPR005821:Ion transport, 450013322$IPR014873:Voltage-dependent calcium channel, alpha-1 subunit, IQ domain, 450016534$IPR018249:EF-HAND 2]
calcium channel, voltage-dependent, N type, alpha 1B subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038880$hsa04742:Taste transduction, 470038887$hsa04930:Type II diabetes mellitus]
calcium channel, voltage-dependent, N type, alpha 1B subunit,PIR_SUPERFAMILY[630005588$PIRSF005657:voltage-gated calcium channel]
calcium channel, voltage-dependent, N type, alpha 1B subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, N type, alpha 1B subunit,UP_SEQ_FEATURE[850100540$chain:Voltage-dependent N-type calcium channel subunit alpha-1B, 850102574$compositionally biased region:Poly-His, 850102581$compositionally biased region:Poly-Ser, 850103571$domain:EF-hand, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850111061$region of interest:Binding to the beta subunit, 850116205$repeat:I, 850116211$repeat:II, 850116226$repeat:III, 850116236$repeat:IV, 850117295$sequence variant, 850117960$site:Calcium ion selectivity and permeability, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 5 open reading frame 24,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 5 open reading frame 24,UP_SEQ_FEATURE[850097113$chain:UPF0461 protein C5orf24, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
double C2-like domains, alpha,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450001391$IPR001565:Synaptotagmin, 450013151$IPR014638:Double C2 protein, alpha/beta/gamma type, 450016334$IPR018029:C2 membrane targeting protein]
double C2-like domains, alpha,PIR_SUPERFAMILY[630028411$PIRSF036931:Doc2, 630028412$PIRSF036931:double C2 protein, alpha/beta/gamma types]
double C2-like domains, alpha,SMART[760000211$SM00239:C2]
double C2-like domains, alpha,SP_PIR_KEYWORDS[790000211$calcium, 790000212$calcium binding, 790000216$calcium/phospholipid-binding, 790000263$cell junction, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000522$exocytosis, 790000897$lysosome, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001475$synapse, 790001477$Synaptosome]
double C2-like domains, alpha,UP_SEQ_FEATURE[850016313$chain:Double C2-like domain-containing protein alpha, 850103200$domain:C2 1, 850103201$domain:C2 2, 850113006$region of interest:Interaction with UNC13D, 850117294$sequence conflict, 850117295$sequence variant]
fibronectin type III domain containing 8,INTERPRO[450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
fibronectin type III domain containing 8,PIR_SUPERFAMILY[630009689$PIRSF011303:human hypothetical protein DKFZp434H2215.1]
fibronectin type III domain containing 8,SMART[760000051$SM00060:FN3]
fibronectin type III domain containing 8,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
fibronectin type III domain containing 8,UP_SEQ_FEATURE[850019443$chain:Fibronectin type III domain-containing protein 8, 850103799$domain:Fibronectin type-III, 850117295$sequence variant]
histone H3-like,INTERPRO[450000140$IPR000164:Histone H3, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
histone H3-like,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
histone H3-like,PIR_SUPERFAMILY[630002185$PIRSF002051:histone H3]
histone H3-like,SMART[760000374$SM00428:H3]
histone H3-like,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000315$chromosomal protein, 790000326$citrullination, 790000356$complete proteome, 790000466$dna-binding, 790000953$methylation, 790001058$nucleosome core, 790001065$nucleus, 790001162$phosphoprotein]
histone H3-like,UP_SEQ_FEATURE[850024072$chain:Histone H3-like, 850106258$modified residue, 850117294$sequence conflict]
human immunodeficiency virus type I enhancer binding protein 2,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
human immunodeficiency virus type I enhancer binding protein 2,PIR_SUPERFAMILY[630003880$PIRSF003876:HIV-EP2 enhancer-binding protein]
human immunodeficiency virus type I enhancer binding protein 2,SMART[760000323$SM00355:ZnF_C2H2]
human immunodeficiency virus type I enhancer binding protein 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000473$duplication, 790000811$isopeptide bond, 790000936$metal binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
human immunodeficiency virus type I enhancer binding protein 2,UP_SEQ_FEATURE[850065200$chain:Transcription factor HIVEP2, 850102404$compositionally biased region:Arg-rich, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102597$compositionally biased region:Ser-rich, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850109748$region of interest:10 X 4 AA tandem repeats of S-P-[RGMKC]- [RK], 850115074$repeat:1, 850115131$repeat:10, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4]
leucine rich repeat containing 70,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
leucine rich repeat containing 70,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP]
leucine rich repeat containing 70,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790000919$membrane, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
leucine rich repeat containing 70,UP_SEQ_FEATURE[850028428$chain:Leucine-rich repeat-containing protein 70, 850105770$glycosylation site:N-linked (GlcNAc...), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117814$signal peptide, 850118623$transmembrane region]
metallothionein-like 5, testis-specific (tesmin),INTERPRO[450004637$IPR005172:Tesmin/TSO1-like, CXC]
metallothionein-like 5, testis-specific (tesmin),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001426$spermatogenesis]
metallothionein-like 5, testis-specific (tesmin),UP_SEQ_FEATURE[850063854$chain:Tesmin, 850103465$domain:CXC 1, 850103466$domain:CXC 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
mitochondrial carrier triple repeat 1,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
mitochondrial carrier triple repeat 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
mitochondrial carrier triple repeat 1,UP_SEQ_FEATURE[850031848$chain:Mitochondrial carrier triple repeat protein 1, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117295$sequence variant, 850118623$transmembrane region]
nuclear receptor subfamily 2, group C, member 2,INTERPRO[450000278$IPR000324:Vitamin D receptor, 450000459$IPR000536:Nuclear hormone receptor, ligand-binding, core, 450001442$IPR001628:Zinc finger, nuclear hormone receptor-type, 450001527$IPR001723:Steroid hormone receptor, 450008168$IPR008946:Nuclear hormone receptor, ligand-binding, 450011732$IPR013088:Zinc finger, NHR/GATA-type]
nuclear receptor subfamily 2, group C, member 2,PIR_SUPERFAMILY[630002644$PIRSF002526:orphan nuclear receptor TR2/TR4]
nuclear receptor subfamily 2, group C, member 2,SMART[760000350$SM00399:ZnF_C4, 760000376$SM00430:HOLI]
nuclear receptor subfamily 2, group C, member 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001301$receptor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
nuclear receptor subfamily 2, group C, member 2,UP_SEQ_FEATURE[850035050$chain:Nuclear receptor subfamily 2 group C member 2, 850102946$DNA-binding region:Nuclear receptor, 850106258$modified residue, 850117294$sequence conflict, 850118866$zinc finger region:NR C4-type]
parvin, gamma,INTERPRO[450001520$IPR001715:Calponin-like actin-binding]
parvin, gamma,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion]
parvin, gamma,SMART[760000025$SM00033:CH]
parvin, gamma,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000256$cell adhesion, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000919$membrane, 790001304$repeat]
parvin, gamma,UP_SEQ_FEATURE[850020571$chain:Gamma-parvin, 850103318$domain:CH 1, 850103319$domain:CH 2, 850118574$splice variant]
polycomb group ring finger 3,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
polycomb group ring finger 3,SMART[760000158$SM00184:RING]
polycomb group ring finger 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
polycomb group ring finger 3,UP_SEQ_FEATURE[850039823$chain:Polycomb group RING finger protein 3, 850118574$splice variant, 850118911$zinc finger region:RING-type]
protein tyrosine phosphatase, non-receptor type 18 (brain-derived),INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, non-receptor type 18 (brain-derived),SMART[760000168$SM00194:PTPc]
protein tyrosine phosphatase, non-receptor type 18 (brain-derived),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001261$protein phosphatase, 790001301$receptor]
protein tyrosine phosphatase, non-receptor type 18 (brain-derived),UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850067651$chain:Tyrosine-protein phosphatase non-receptor type 18, 850105593$domain:Tyrosine-protein phosphatase, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
ribonucleotide reductase M2 B (TP53 inducible),INTERPRO[450000308$IPR000358:Ribonucleotide reductase, 450011044$IPR012348:Ribonucleotide reductase-related]
ribonucleotide reductase M2 B (TP53 inducible),KEGG_PATHWAY[470038742$hsa00230:Purine metabolism, 470038744$hsa00240:Pyrimidine metabolism, 470038764$hsa00480:Glutathione metabolism, 470038836$hsa04115:p53 signaling pathway]
ribonucleotide reductase M2 B (TP53 inducible),OMIM_DISEASE[520003343$Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy]
ribonucleotide reductase M2 B (TP53 inducible),PIR_SUPERFAMILY[630000416$PIRSF000355:ribonucleoside-diphosphate reductase class I, small subunit]
ribonucleotide reductase M2 B (TP53 inducible),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000452$DNA damage, 790000459$dna repair, 790000460$dna replication, 790000802$iron, 790000937$metal-binding, 790001065$nucleus, 790001092$oxidoreductase, 790001212$polymorphism]
ribonucleotide reductase M2 B (TP53 inducible),UP_SEQ_FEATURE[850057841$chain:Ribonucleoside-diphosphate reductase subunit M2 B, 850105852$helix, 850106046$metal ion-binding site:Iron 1, 850106051$metal ion-binding site:Iron 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118624$turn]
ribosomal protein S6 kinase, 70kDa, polypeptide 1,BIOCARTA[30000074$h_ctcfPathway:CTCF: First Multivalent Nuclear Factor, 30000095$h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase, 30000146$h_igf1mtorpathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway, 30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation, 30000158$h_il4Pathway:IL 4 signaling pathway, 30000180$h_mapkPathway:MAPKinase Signaling Pathway, 30000195$h_mTORPathway:mTOR Signaling Pathway, 30000199$h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart), 30000242$h_ptdinsPathway:Phosphoinositides and their downstream targets., 30000246$h_rac1Pathway:Rac 1 cell motility signaling pathway]
ribosomal protein S6 kinase, 70kDa, polypeptide 1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450014562$IPR016238:Ribosomal protein S6 kinase, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related, 450016207$IPR017892:Protein kinase, C-terminal]
ribosomal protein S6 kinase, 70kDa, polypeptide 1,KEGG_PATHWAY[470038828$hsa04012:ErbB signaling pathway, 470038842$hsa04150:mTOR signaling pathway, 470038850$hsa04350:TGF-beta signaling pathway, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038882$hsa04910:Insulin signaling pathway, 470038911$hsa05221:Acute myeloid leukemia]
ribosomal protein S6 kinase, 70kDa, polypeptide 1,PIR_SUPERFAMILY[630000712$PIRSF000605:ribosomal protein S6 kinase, 630000713$PIRSF000605:Ribsml_S6_kin_1]
ribosomal protein S6 kinase, 70kDa, polypeptide 1,SMART[760000115$SM00133:S_TK_X, 760000193$SM00220:S_TKc]
ribosomal protein S6 kinase, 70kDa, polypeptide 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000050$alternative initiation, 790000051$alternative initiators, 790000134$ATP, 790000138$atp-binding, 790000263$cell junction, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000983$monomer, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001329$ribosomal protein, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001475$synapse, 790001477$Synaptosome, 790001547$transferase]
ribosomal protein S6 kinase, 70kDa, polypeptide 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850057906$chain:Ribosomal protein S6 kinase beta-1, 850103028$domain:AGC-kinase C-terminal, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118574$splice variant]
ring finger protein 216,INTERPRO[450002535$IPR002867:Zinc finger, C6HC-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site]
ring finger protein 216,SMART[760000562$SM00647:IBR]
ring finger protein 216,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000733$host-virus interaction, 790000859$ligase, 790000937$metal-binding, 790001162$phosphoprotein, 790001304$repeat, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
ring finger protein 216,UP_SEQ_FEATURE[850016724$chain:E3 ubiquitin-protein ligase RNF216, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118829$zinc finger region:IBR-type, 850118912$zinc finger region:RING-type 1, 850118915$zinc finger region:RING-type 2]
sterol regulatory element binding transcription factor 2,BIOCARTA[30000264$h_s1pPathway:SREBP control of lipid synthesis]
sterol regulatory element binding transcription factor 2,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450010429$IPR011598:Helix-loop-helix DNA-binding]
sterol regulatory element binding transcription factor 2,PIR_SUPERFAMILY[630005380$PIRSF005456:sterol regulatory element-binding protein]
sterol regulatory element binding transcription factor 2,SMART[760000321$SM00353:HLH]
sterol regulatory element binding transcription factor 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000305$cholesterol metabolism, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000445$direct protein sequencing, 790000449$DNA binding, 790000466$dna-binding, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000873$lipid metabolism, 790000919$membrane, 790000924$membrane protein, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001442$steroid metabolism, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation, 790001555$transmembrane]
sterol regulatory element binding transcription factor 2,UP_SEQ_FEATURE[850044445$chain:Processed sterol regulatory element- binding protein 2, 850062480$chain:Sterol regulatory element-binding protein 2, 850102485$compositionally biased region:Gln-rich, 850102532$compositionally biased region:Gly/Pro/Ser-rich, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104712$domain:Leucine-zipper, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112490$region of interest:Interaction with LMNA, 850114918$region of interest:Transcriptional activation (acidic), 850117294$sequence conflict, 850117295$sequence variant, 850118021$site:Cleavage; by caspase-3 and caspase-7, 850118106$site:Cleavage; by S1P, 850118107$site:Cleavage; by S2P, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region, 850118624$turn]
transmembrane protein 110; musculoskeletal, embryonic nuclear protein 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001065$nucleus, 790001555$transmembrane]
transmembrane protein 110; musculoskeletal, embryonic nuclear protein 1,UP_SEQ_FEATURE[850032847$chain:Musculoskeletal embryonic nuclear protein 1, 850066011$chain:Transmembrane protein 110, 850117610$short sequence motif:Nuclear localization signal, 850118623$transmembrane region]
zinc finger protein 655,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 655,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 655,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 655,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 655,UP_SEQ_FEATURE[850101829$chain:Zinc finger protein 655, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6]
